| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $15.3M | -28.8% |
| SG&A Expense | $9.8M | -8.9% |
| Operating Income | -$24.4M | +22.6% |
| Pre-tax Income | -$24.1M | +22.1% |
| Net Income | -$24.1M | +22.1% |
| EPS (Basic) | -$2.87 | +50.6% |
| EPS (Diluted) | -$2.87 | +50.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $14.6M | -31.5% |
| Current Assets | $15.6M | -30.2% |
| Total Assets | $26.5M | -25.5% |
| Current Liabilities | $7.3M | -8.7% |
| Total Liabilities | $16.1M | -9.1% |
| Stockholders' Equity | $10.3M | -41.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$20.8M | +25.2% |
| Capital Expenditures | $13K | -40.9% |
| Investing Cash Flow | -$13K | +40.9% |
| Financing Cash Flow | $14.1M | — |
| Free Cash Flow | -$20.8M | +25.2% |